Research Article
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
Table 4
Correlation between serum level of lncRNAs PTENP1, PTTG3P, and SPRY4-IT1 and clinicopathological characteristics in 129 HCC patients.
| Features | PTENP1 | PTTG3P | SPRY4-IT1 | Low () | High () | | Low () | High () | | Low () | High () | |
| Gender | | | 0.972 | | | 0.136 | | | 0.636 | Male | 56 | 55 | | 53 | 58 | | 55 | 56 | | Female | 9 | 9 | | 12 | 6 | | 10 | 8 | | Age | | | 0.124 | | | 0.185 | | | 0.016 | ≤55 | 31 | 22 | | 23 | 30 | | 20 | 33 | | >55 | 34 | 42 | | 42 | 34 | | 45 | 31 | | HBsAg | | | 0.558 | | | 0.870 | | | 0.496 | Positive | 49 | 51 | | 50 | 50 | | 52 | 48 | | Negative | 16 | 13 | | 15 | 14 | | 13 | 16 | | AFP level | | | 0.064 | | | 0.089 | | | 0.858 | ≤20 ng/mL | 23 | 33 | | 33 | 23 | | 28 | 27 | | >20 ng/mL | 42 | 31 | | 32 | 41 | | 36 | 37 | | Tumor size | | | 0.897 | | | 0.612 | | | 0.530 | ≤3 cm | 21 | 20 | | 22 | 19 | | 19 | 22 | | >3 cm | 44 | 44 | | 43 | 45 | | 46 | 42 | | Tumor number | | | 0.968 | | | 0.329 | | | 0.329 | Single | 54 | 53 | | 56 | 51 | | 56 | 51 | | Multiple | 11 | 11 | | 9 | 13 | | 9 | 13 | | GGT (U/L) | 90 (14-1034) | 79.5 (13-2000) | 0.611 | 70 (13-2000) | 85.5 (14-1034) | 0.042 | 86 (13-2000) | 65 (15-710) | 0.517 | ALT (U/L) | 38 (12-1198) | 35 (7-402) | 0.202 | 33 (7-402) | 42.5 (12-1198) | 0.316 | 33.5 (12-621) | 49 (7-1198) | 0.016 | AST (U/L) | 50 (17-1474) | 38 (17-577) | 0.306 | 37 (18-577) | 52 (17-1474) | 0.095 | 36.5 (17-412) | 50 (18-1474) | 0.097 | TP (g/L) | 68.2 (43.4-84.8) | 69.1 (55.5-80.6) | 0.504 | 68.6 (55.5-80.6) | 68.6 (43.4-84.8) | 0.983 | 68.6 (46.8-80.6) | 68.7 (43.4-84.8) | 0.243 | ALB (g/L) | 39.4 (21.4-48.6) | 40.5 (23.8-48.9) | 0.301 | 40.3 (23.8-48.9) | 39.5 (21.4-48.6) | 0.539 | 39.6 (21.4-48.9) | 40.2 (23.6-48.6) | 0.468 |
|
|
. AFP: alpha fetoprotein; GGT: gamma-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartic transaminase; TP: total protein; ALB: albumin. |